|
|
"A comprehensive, collaborative elections resource."
|
Drug pacts keep some generics off market - FTC
|
|---|
| Parent(s) |
Issue
|
| Contributor | Servo |
| Last Edited | Servo Apr 25, 2006 11:22am |
| Logged |
0
|
| Category | News |
| News Date | Tuesday, April 25, 2006 05:00:00 PM UTC0:0 |
| Description | Brand-name drug makers are striking more deals with generic rivals to restrict the introduction of cheaper generic drugs, antitrust authorities said on Monday.
Emboldened by recent victories in court, pharmaceutical companies are using controversial settlements that entail payments to generic rivals which promise to restrict selling competing generic drugs, a Federal Trade Commission official said in a speech on Monday.
"We are seeing far more settlements today that potentially raise competition concerns," FTC Commissioner Jon Leibowitz said in prepared remarks for a Philadelphia business group. |
| Share |
|
|
2¢
|
|
| Article | Read Full Article |
|
| Date |
Category |
Headline |
Article |
Contributor |
|
|
